|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
306 a.a.
|
 |
|
|
|
|
|
|
|
229 a.a.
|
 |
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of HIV-gp120 core in complex with cd4-binding site antibody b13, space group c2221
|
|
Structure:
|
 |
HIV-1 hxbc2 gp120 core. Chain: g, a. Engineered: yes. Mutation: yes. Fab b13 heavy chain. Chain: h, b. Engineered: yes. Fab b13 light chain. Chain: l, c.
|
|
Source:
|
 |
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxbc2. Gene: env. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293f. Homo sapiens. Human.
|
|
Resolution:
|
 |
|
3.20Å
|
R-factor:
|
0.198
|
R-free:
|
0.237
|
|
|
Authors:
|
 |
L.Chen,Y.D.Kwon,T.Zhou,X.Wu,S.O'Dell,L.Cavacini,A.J.Hessell, M.Pancera,M.Tang,L.Xu,Z.Y.Yang,M.Y.Zhang,J.Arthos,D.R.Burton, D.S.Dimitrov,G.J.Nabel,M.Posner,J.Sodroski,R.Wyatt,J.R.Mascola, P.D.Kwong
|
Key ref:
|
 |
L.Chen
et al.
(2009).
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120.
Science,
326,
1123-1127.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
22-Jul-09
|
Release date:
|
17-Nov-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04578
(ENV_HV1H2) -
Envelope glycoprotein gp160 from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
856 a.a.
306 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
326:1123-1127
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120.
|
|
L.Chen,
Y.Do Kwon,
T.Zhou,
X.Wu,
S.O'Dell,
L.Cavacini,
A.J.Hessell,
M.Pancera,
M.Tang,
L.Xu,
Z.Y.Yang,
M.Y.Zhang,
J.Arthos,
D.R.Burton,
D.S.Dimitrov,
G.J.Nabel,
M.R.Posner,
J.Sodroski,
R.Wyatt,
J.R.Mascola,
P.D.Kwong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to
antibodies. However, most antibodies that interact with this site cannot
neutralize HIV-1. To understand the basis of this resistance, we determined
co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS)
antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited
approach angles to gp120 similar to those of CD4 and a rare, broadly
neutralizing CD4BS antibody, b12. Slight differences in recognition, however,
resulted in substantial differences in F105- and b13-bound conformations
relative to b12-bound gp120. Modeling and binding experiments revealed these
conformations to be poorly compatible with the viral spike. This
incompatibility, the consequence of slight differences in CD4BS recognition,
renders HIV-1 resistant to all but the most accurately targeted antibodies.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
View larger version (50K): [in
this window] [in
a new window] Fig. 2. Epitopes, bound conformations, and
trimer modeling. (A) Epitope hydrophobicity. The surface of
gp120 is shown in gray, with hydrophobic residues highlighted in
green. Binding surfaces for CD4, F105, b12, and b13 are outlined
in orange. (B) Ligand-bound conformation of gp120. Polypeptides
of gp120 are depicted in ribbon representation with inner
domains shown in light gray, outer domains in dark gray, and
regions that in the CD4-bound state correspond to the bridging
sheet shown in red. Residues 109 and 428 are highlighted in blue
and shown in stick representation. (C) Viral spike
compatibility. Density maps derived from the cryo–electron
tomography of HIV-1 BaL isolate spike are shown in gray for CD4
and 17b- and b12-bound states (first and third from left,
respectively), along with optimal fits of atomic-level models
(30). To model F105- and b13-bound forms of gp120 into likely
viral spike orientations, the invariant β-sandwich of the gp120
inner domain was superimposed. Likely clashes of V1/V2 in the
superimposed conformation with neighboring protomers close to
the trimer axis are highlighted in light blue.
|
 |
Figure 3.
View larger version (42K): [in
this window] [in
a new window] Fig. 3. Immune evasion at the site of initial
CD4 attachment. (A) Recognition similarity. Centers of
recognition for CD4, F105, b12, and b13. After superposition of
gp120 outer domains, the centers of the recognition surface of
each ligand on gp120 is denoted by balls for CD4 (yellow), F105
(blue), b12 (red), and b13 (purple). (B) Immune evasion. The
initial site of CD4 attachment (cross-hatched yellow surface) is
circumscribed by a combination of glycan (green) and
conformational constraints. The surface on gp120 recognized by
F105, b12, and b13 (that strays beyond the site of CD4
attachment) is shown in blue, red, and purple, respectively.
Glycosylation sterically crowds the immune response toward the
bridging-sheet region (blue surface that F105 recognizes) or
toward the V3 region (purple surface that b13 recognizes) (48).
In either case, recognition of these regions of gp120 results in
antibody-bound conformations of gp120 that are poorly compatible
with the functional spikes of HIV-1 virions from tier 2 primary
isolates.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2009,
326,
1123-1127)
copyright 2009.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Emileh,
and
C.F.Abrams
(2011).
A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120.
|
| |
Proteins,
79,
537-546.
|
 |
|
|
|
|
 |
C.R.Ruprecht,
A.Krarup,
L.Reynell,
A.M.Mann,
O.F.Brandenberg,
L.Berlinger,
I.A.Abela,
R.R.Regoes,
H.F.Günthard,
P.Rusert,
and
A.Trkola
(2011).
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.
|
| |
J Exp Med,
208,
439-454.
|
 |
|
|
|
|
 |
I.Mikell,
D.N.Sather,
S.A.Kalams,
M.Altfeld,
G.Alter,
and
L.Stamatatos
(2011).
Characteristics of the earliest cross-neutralizing antibody response to HIV-1.
|
| |
PLoS Pathog,
7,
e1001251.
|
 |
|
|
|
|
 |
J.S.McLellan,
M.Pancera,
C.Carrico,
J.Gorman,
J.P.Julien,
R.Khayat,
R.Louder,
R.Pejchal,
M.Sastry,
K.Dai,
S.O'Dell,
N.Patel,
S.Shahzad-ul-Hussan,
Y.Yang,
B.Zhang,
T.Zhou,
J.Zhu,
J.C.Boyington,
G.Y.Chuang,
D.Diwanji,
I.Georgiev,
Y.D.Kwon,
D.Lee,
M.K.Louder,
S.Moquin,
S.D.Schmidt,
Z.Y.Yang,
M.Bonsignori,
J.A.Crump,
S.H.Kapiga,
N.E.Sam,
B.F.Haynes,
D.R.Burton,
W.C.Koff,
L.M.Walker,
S.Phogat,
R.Wyatt,
J.Orwenyo,
L.X.Wang,
J.Arthos,
C.A.Bewley,
J.R.Mascola,
G.J.Nabel,
W.R.Schief,
A.B.Ward,
I.A.Wilson,
and
P.D.Kwong
(2011).
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
|
| |
Nature,
480,
336-343.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.T.Da,
J.M.Quan,
and
Y.D.Wu
(2011).
Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry.
|
| |
Proteins,
79,
1810-1819.
|
 |
|
|
|
|
 |
A.Hinz,
D.Lutje Hulsik,
A.Forsman,
W.W.Koh,
H.Belrhali,
A.Gorlani,
H.de Haard,
R.A.Weiss,
T.Verrips,
and
W.Weissenhorn
(2010).
Crystal Structure of the Neutralizing Llama V(HH) D7 and Its Mode of HIV-1 gp120 Interaction.
|
| |
PLoS One,
5,
e10482.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.F.Abrams,
and
E.Vanden-Eijnden
(2010).
Large-scale conformational sampling of proteins using temperature-accelerated molecular dynamics.
|
| |
Proc Natl Acad Sci U S A,
107,
4961-4966.
|
 |
|
|
|
|
 |
C.Hager-Braun,
E.O.Hochleitner,
M.K.Gorny,
S.Zolla-Pazner,
R.J.Bienstock,
and
K.B.Tomer
(2010).
Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
|
| |
J Am Soc Mass Spectrom,
21,
1687-1698.
|
 |
|
|
|
|
 |
D.P.Leaman,
H.Kinkead,
and
M.B.Zwick
(2010).
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.
|
| |
J Virol,
84,
3382-3395.
|
 |
|
|
|
|
 |
H.W.Virgin,
and
B.D.Walker
(2010).
Immunology and the elusive AIDS vaccine.
|
| |
Nature,
464,
224-231.
|
 |
|
|
|
|
 |
I.Shrivastava,
and
J.M.LaLonde
(2010).
Fluctuation dynamics analysis of gp120 envelope protein reveals a topologically based communication network.
|
| |
Proteins,
78,
2935-2949.
|
 |
|
|
|
|
 |
J.Liu,
E.R.Wright,
and
H.Winkler
(2010).
3D visualization of HIV virions by cryoelectron tomography.
|
| |
Methods Enzymol,
483,
267-290.
|
 |
|
|
|
|
 |
J.Pietzsch,
J.F.Scheid,
H.Mouquet,
F.Klein,
M.S.Seaman,
M.Jankovic,
D.Corti,
A.Lanzavecchia,
and
M.C.Nussenzweig
(2010).
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness.
|
| |
J Exp Med,
207,
1995-2002.
|
 |
|
|
|
|
 |
J.R.Mascola,
and
D.C.Montefiori
(2010).
The role of antibodies in HIV vaccines.
|
| |
Annu Rev Immunol,
28,
413-444.
|
 |
|
|
|
|
 |
J.S.Klein,
and
P.J.Bjorkman
(2010).
Few and far between: how HIV may be evading antibody avidity.
|
| |
PLoS Pathog,
6,
e1000908.
|
 |
|
|
|
|
 |
K.J.Doores,
C.Bonomelli,
D.J.Harvey,
S.Vasiljevic,
R.A.Dwek,
D.R.Burton,
M.Crispin,
and
C.N.Scanlan
(2010).
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.
|
| |
Proc Natl Acad Sci U S A,
107,
13800-13805.
|
 |
|
|
|
|
 |
L.Kong,
C.C.Huang,
S.J.Coales,
K.S.Molnar,
J.Skinner,
Y.Hamuro,
and
P.D.Kwong
(2010).
Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange.
|
| |
J Virol,
84,
10311-10321.
|
 |
|
|
|
|
 |
L.M.Walker,
and
D.R.Burton
(2010).
Rational antibody-based HIV-1 vaccine design: current approaches and future directions.
|
| |
Curr Opin Immunol,
22,
358-366.
|
 |
|
|
|
|
 |
M.Pancera,
J.S.McLellan,
X.Wu,
J.Zhu,
A.Changela,
S.D.Schmidt,
Y.Yang,
T.Zhou,
S.Phogat,
J.R.Mascola,
and
P.D.Kwong
(2010).
Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.
|
| |
J Virol,
84,
8098-8110.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Pancera,
S.Majeed,
Y.E.Ban,
L.Chen,
C.C.Huang,
L.Kong,
Y.D.Kwon,
J.Stuckey,
T.Zhou,
J.E.Robinson,
W.R.Schief,
J.Sodroski,
R.Wyatt,
and
P.D.Kwong
(2010).
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.
|
| |
Proc Natl Acad Sci U S A,
107,
1166-1171.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Diskin,
P.M.Marcovecchio,
and
P.J.Bjorkman
(2010).
Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.
|
| |
Nat Struct Mol Biol,
17,
608-613.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.D.Taylor,
S.R.Leib,
S.Carpenter,
and
R.H.Mealey
(2010).
Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
|
| |
J Virol,
84,
6536-6548.
|
 |
|
|
|
|
 |
S.Gnanakaran,
M.G.Daniels,
T.Bhattacharya,
A.S.Lapedes,
A.Sethi,
M.Li,
H.Tang,
K.Greene,
H.Gao,
B.F.Haynes,
M.S.Cohen,
G.M.Shaw,
M.S.Seaman,
A.Kumar,
F.Gao,
D.C.Montefiori,
and
B.Korber
(2010).
Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.
|
| |
PLoS Comput Biol,
6,
e1000955.
|
 |
|
|
|
|
 |
S.H.Xiang,
A.Finzi,
B.Pacheco,
K.Alexander,
W.Yuan,
C.Rizzuto,
C.C.Huang,
P.D.Kwong,
and
J.Sodroski
(2010).
A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.
|
| |
J Virol,
84,
3147-3161.
|
 |
|
|
|
|
 |
T.Zhou,
I.Georgiev,
X.Wu,
Z.Y.Yang,
K.Dai,
A.Finzi,
Y.D.Kwon,
J.F.Scheid,
W.Shi,
L.Xu,
Y.Yang,
J.Zhu,
M.C.Nussenzweig,
J.Sodroski,
L.Shapiro,
G.J.Nabel,
J.R.Mascola,
and
P.D.Kwong
(2010).
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
|
| |
Science,
329,
811-817.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.C.Koff
(2010).
Accelerating HIV vaccine development.
|
| |
Nature,
464,
161-162.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|